Protara Therapeutics's total assets for Q1 2026 were $191.92M, a decrease of -8.38% from the previous quarter. TARA total liabilities were $10.71M for the fiscal quarter, a -17.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.